Trial
NCT05849727
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
TQH3821 tablets 200 mg
Why stopped
Per sponsor request.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-20